Expert insights on the future of AI and healthcare.
Welcome to a new series by NCIMI – the National Consortium for Intelligent Medical Imaging.
Join Claire Bloomfield, CEO of NCIMI, and a range of experts from across the UK to explore the opportunities for artificial intelligence in healthcare.
We work with innovating companies from the medi-tech industry, leading consultants and clinicians at NHS trusts across the UK, plus charities and patient groups to explore what AI could to do to improve both diagnosis and treatment of a range of conditions.
Using healthcare data to improve diagnosis and treatment of patients with a huge range of medical conditions is right at the heart of NCIMI’s mission.
But what are the ethical and legal implications of using anonymous patient data to develop medical technology?
NCIMI has been working closely with Future Care Capital (FCC) and Anthony Collins Solicitors LLP to undertake an analysis of the legal provisions and issues impacting research and commercial usage of healthcare data.
On this episode of NCIMI Voices, Claire talks to Annemarie Naylor, Director of Policy and Strategy at FCC, who was instrumental in developing the report - Research and Commercial Use of Healthcare Data: a review of the legal issues surrounding the potential ownership and exploitation of health data.
And to bring a patient perspective, we have Neil McClements who is CEO of the charity Haemochromatosis UK.
Together, they discuss the opportunities and challenges of working with patient data for the purposes of discovery.
About Haemochromatosis UK
Haemochromatosis is a genetic condition where a person absorbs too much iron from the diet, creating “iron overload”. Neil talks about how use of patient data is as important as donating blood – something his service users know a lot about, since regular blood donation is an effective treatment for people living with Haemochromatosis.
Impact of Iron Overload – report launched at Parliament in late 2018 : https://www.haemochromatosis.org.uk/the-impact-of-iron-overload
State of the Nation – our most recent report delivered to the All Party Parliamentary Group on GH : https://www.haemochromatosis.org.uk/state-of-the-nation-2020
LinkedIn page: https://www.linkedin.com/company/42963713/admin/
NCIMI’s approach to ethics and data:
Blog by Claire and Annemarie – https://futurecarecapital.org.uk/latest/use-of-healthcare-data-in-uncertain-times
Full report here: https://futurecarecapital.org.uk/research/research-and-commercial-use-of-healthcare-data. (Also attached)
Future Care Capital (FCC) is an independent charity shaping the future of health and social care.
They drive innovation and improvement through leading edge research and policy insights, and by bringing together policy makers and practitioners.
Hear from NCIMI’s CEO Claire Bloomfield about how the NCIMI network is responding to the Covid 19 crisis.
Claire is joined by Dr George Harston, Chief Medical Officer at Brainomix and Dr Kiruba Nagaratnam, consultant stroke physician and geriatrician, and clinical lead for stroke medicine at the Royal Berkshire Hospital.
Royal Berks Hospital is the first hospital in the Thames Valley to start using the cutting-edge AI software developed by Oxford-based Brainomix, used in the Emergency Department to help clinicians quickly diagnose stroke.
This in turn will speed up doctors' decision making around treatment and, when necessary, fast forward certain patients to specialist centres for clot retrieval treatment.
George discusses how the NHS is working in a joined up way- and how communication is key to be resilient in the face of this challenge.
Kiruba shares how he sees a system “devolving” to be more responsive in supporting rapid adoption of new technologies.
It's an energetic and positive take on how the NHS and expert medical partners are able to respond and mobilise technology to support patient care.
Thank you to NCIMI's funders, Innovate UK.
You can read more about e-Stroke Suite and Covid-19 here: https://brainomix.com/news/78
Check out the NCIM website here
Follow Claire on LinkedIn
Follow us on Twitter: @NCIMImaging
Join Claire Bloomfield, Fergus Gleeson and Jim Davies from the University of Oxford's NCIMI consortium as they share their experiences of integrating AI into healthcare systems.
Delivering effective AI imaging solutions into the NHS is a huge challenge, requiring high-quality data, evidence and wide-scale collaboration to refine, validate and monitor each new intervention.
NCIMI has established a unique multi-stakeholder approach to address these challenges. By involving NHS Trusts, commercial partners, such as GE, and patient groups, they have created an environment in which experts can collaborate effectively, giving the consortium the power and insight to make AI in healthcare a reality.
To follow the latest news from NCIMI go to:
Follow us on Twitter:
And follow Claire on Linked In at:
You can also get in touch with the team by email: